Acadia Pharmaceuticals Inc Stock, NASDAQ:ACAD
12830 El Camino Real, Suite 400, San Diego, California 92130-3331
United States of America
Number of Employees: 514
ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firm's products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.